APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Animal Biotechnology

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Animal Biotechnology Market Analysis and Forecast 2026-2032

Report ID 173963810220 December 2025192 pages

Choose your research edition.

Industry ResearchAnimal Biotechnology Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Biotechnology Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Animal Biotechnology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Biotechnology Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Biotechnology Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Animal Biotechnology market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Animal Biotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Animal Biotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Animal Biotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Animal Biotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Animal Biotechnology include Biogenesis Bago, Boehringer Inghlem, Santa Cruz Biotechnology, Inc., Virbac Inc., Bayer AG, Pfizer, Inc., Merck &, Inc., Sanofi and Zoetis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Animal Biotechnology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Animal Biotechnology, also provides the revenue of main regions and countries. Of the upcoming market potential for Animal Biotechnology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Biotechnology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Biotechnology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Animal Biotechnology revenue, projected growth trends, production technology, application and end-user industry.

Animal Biotechnology Segment by Company

Biogenesis Bago

Boehringer Inghlem

Santa Cruz Biotechnology, Inc.

Virbac Inc.

Bayer AG

Pfizer, Inc.

Merck &, Inc.

Sanofi

Zoetis

Animal Biotechnology Segment by Type

Diagnostic Tests

Vaccines

Drugs

Reporductive & Genetic Produtcs

Animal Biotechnology Segment by Application

Food Safety and Drug Development

Preventive Care for Animals

Development of Animal Pharmaceuticals

Others

Animal Biotechnology Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Biotechnology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Animal Biotechnology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Animal Biotechnology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Biotechnology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Animal Biotechnology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Diagnostic Tests Major Player Table 3. Vaccines Major Player Table 4. Drugs Major Player Table 5. Reporductive & Genetic Produtcs Major Player Table 6. Global Animal Biotechnology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Food Safety and Drug Development Major Player Table 8. Preventive Care for Animals Major Player Table 9. Development of Animal Pharmaceuticals Major Player Table 10. Others Major Player Table 11. Animal Biotechnology Industry Trends Table 12. Animal Biotechnology Industry Drivers Table 13. Animal Biotechnology Industry Opportunities and Challenges Table 14. Animal Biotechnology Industry Restraints Table 15. Global Animal Biotechnology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Animal Biotechnology Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Animal Biotechnology Market Share by Region (2021-2026) Table 18. Global Animal Biotechnology Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Animal Biotechnology Market Share by Region (2027-2032) Table 20. Global Animal Biotechnology Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Animal Biotechnology Revenue Market Share by Players (2021-2026) Table 22. Global Animal Biotechnology Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Animal Biotechnology Key Players Headquarters & Area Served Table 24. Global Animal Biotechnology Players, Product Type & Application Table 25. Global Animal Biotechnology Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Animal Biotechnology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Animal Biotechnology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Animal Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Animal Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Animal Biotechnology Revenue Market Share by Type (2021-2026) Table 32. Global Animal Biotechnology Revenue Market Share by Type (2027-2032) Table 33. Global Animal Biotechnology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Animal Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Animal Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Animal Biotechnology Revenue Market Share by Application (2021-2026) Table 37. Global Animal Biotechnology Revenue Market Share by Application (2027-2032) Table 38. Biogenesis Bago Company Information Table 39. Biogenesis Bago Business Overview Table 40. Biogenesis Bago Animal Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Biogenesis Bago Animal Biotechnology Product Portfolio Table 42. Biogenesis Bago Recent Development Table 43. Boehringer Inghlem Company Information Table 44. Boehringer Inghlem Business Overview Table 45. Boehringer Inghlem Animal Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Boehringer Inghlem Animal Biotechnology Product Portfolio Table 47. Boehringer Inghlem Recent Development Table 48. Santa Cruz Biotechnology, Inc. Company Information Table 49. Santa Cruz Biotechnology, Inc. Business Overview Table 50. Santa Cruz Biotechnology, Inc. Animal Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Santa Cruz Biotechnology, Inc. Animal Biotechnology Product Portfolio Table 52. Santa Cruz Biotechnology, Inc. Recent Development Table 53. Virbac Inc. Company Information Table 54. Virbac Inc. Business Overview Table 55. Virbac Inc. Animal Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Virbac Inc. Animal Biotechnology Product Portfolio Table 57. Virbac Inc. Recent Development Table 58. Bayer AG Company Information Table 59. Bayer AG Business Overview Table 60. Bayer AG Animal Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Bayer AG Animal Biotechnology Product Portfolio Table 62. Bayer AG Recent Development Table 63. Pfizer, Inc. Company Information Table 64. Pfizer, Inc. Business Overview Table 65. Pfizer, Inc. Animal Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Pfizer, Inc. Animal Biotechnology Product Portfolio Table 67. Pfizer, Inc. Recent Development Table 68. Merck &, Inc. Company Information Table 69. Merck &, Inc. Business Overview Table 70. Merck &, Inc. Animal Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Merck &, Inc. Animal Biotechnology Product Portfolio Table 72. Merck &, Inc. Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Animal Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Sanofi Animal Biotechnology Product Portfolio Table 77. Sanofi Recent Development Table 78. Zoetis Company Information Table 79. Zoetis Business Overview Table 80. Zoetis Animal Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Zoetis Animal Biotechnology Product Portfolio Table 82. Zoetis Recent Development Table 83. North America Animal Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 84. North America Animal Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 85. North America Animal Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Animal Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Animal Biotechnology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. North America Animal Biotechnology Revenue by Country (2021-2026) & (US$ Million) Table 89. North America Animal Biotechnology Revenue by Country (US$ Million) & (2027-2032) Table 90. Europe Animal Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Animal Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Animal Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Animal Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Animal Biotechnology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Europe Animal Biotechnology Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Animal Biotechnology Revenue by Country (US$ Million) & (2027-2032) Table 97. China Animal Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 98. China Animal Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 99. China Animal Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 100. China Animal Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 101. Asia Animal Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 102. Asia Animal Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 103. Asia Animal Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 104. Asia Animal Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Animal Biotechnology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Asia Animal Biotechnology Revenue by Region (US$ Million) & (2021-2026) Table 107. Asia Animal Biotechnology Revenue by Region (US$ Million) & (2027-2032) Table 108. SAMEA Animal Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 109. SAMEA Animal Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 110. SAMEA Animal Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 111. SAMEA Animal Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 112. SAMEA Animal Biotechnology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. SAMEA Animal Biotechnology Revenue by Country (2021-2026) & (US$ Million) Table 114. SAMEA Animal Biotechnology Revenue by Country (US$ Million) & (2027-2032) Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Animal Biotechnology Image Figure 2. Global Animal Biotechnology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Biotechnology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Diagnostic Tests Image Figure 5. Vaccines Image Figure 6. Drugs Image Figure 7. Reporductive & Genetic Produtcs Image Figure 8. Global Animal Biotechnology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Animal Biotechnology Market Size Share 2021 VS 2025 VS 2032 Figure 10. Food Safety and Drug Development Image Figure 11. Preventive Care for Animals Image Figure 12. Development of Animal Pharmaceuticals Image Figure 13. Others Image Figure 14. Global Animal Biotechnology Market Size (US$ Million) & (2021-2032) Figure 15. Global Animal Biotechnology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Animal Biotechnology Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Animal Biotechnology Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Animal Biotechnology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Animal Biotechnology Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Animal Biotechnology Revenue Market Share by Type (2021-2032) Figure 22. Global Animal Biotechnology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Animal Biotechnology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Animal Biotechnology Revenue Market Share by Application (2021-2032) Figure 25. North America Animal Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Animal Biotechnology Revenue Share by Type (2021-2032) Figure 27. North America Animal Biotechnology Revenue Share by Application (2021-2032) Figure 28. North America Animal Biotechnology Revenue Share by Country (2021-2032) Figure 29. United States Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Animal Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Animal Biotechnology Revenue Share by Type (2021-2032) Figure 34. Europe Animal Biotechnology Revenue Share by Application (2021-2032) Figure 35. Europe Animal Biotechnology Revenue Share by Country (2021-2032) Figure 36. Germany Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Animal Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Animal Biotechnology Revenue Share by Type (2021-2032) Figure 46. China Animal Biotechnology Revenue Share by Application (2021-2032) Figure 47. Asia Animal Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Animal Biotechnology Revenue Share by Type (2021-2032) Figure 49. Asia Animal Biotechnology Revenue Share by Application (2021-2032) Figure 50. Asia Animal Biotechnology Revenue Share by Region (2021-2032) Figure 51. Japan Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Animal Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Animal Biotechnology Revenue Share by Type (2021-2032) Figure 59. SAMEA Animal Biotechnology Revenue Share by Application (2021-2032) Figure 60. SAMEA Animal Biotechnology Revenue Share by Country (2021-2032) Figure 61. Brazil Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Animal Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Tests
  • Vaccines
  • Drugs
  • Reporductive & Genetic Produtcs
Applications
  • Food Safety and Drug Development
  • Preventive Care for Animals
  • Development of Animal Pharmaceuticals
  • Others
Companies covered
  • Biogenesis Bago
  • Boehringer Inghlem
  • Santa Cruz Biotechnology, Inc.
  • Virbac Inc.
  • Bayer AG
  • Pfizer, Inc.
  • Merck &, Inc.
  • Sanofi
  • Zoetis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Animal Biotechnology Market by Type
  3. 1.2.1 Global Animal Biotechnology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Diagnostic Tests
  5. 1.2.3 Vaccines
  6. 1.2.4 Drugs
  7. 1.2.5 Reporductive & Genetic Produtcs
  8. 1.3 Animal Biotechnology Market by Application
  9. 1.3.1 Global Animal Biotechnology Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Food Safety and Drug Development
  11. 1.3.3 Preventive Care for Animals
  12. 1.3.4 Development of Animal Pharmaceuticals
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Animal Biotechnology Market Dynamics
  1. 2.1 Animal Biotechnology Industry Trends
  2. 2.2 Animal Biotechnology Industry Drivers
  3. 2.3 Animal Biotechnology Industry Opportunities and Challenges
  4. 2.4 Animal Biotechnology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Animal Biotechnology Market Perspective (2021-2032)
  2. 3.2 Global Animal Biotechnology Growth Trends by Region
  3. 3.2.1 Global Animal Biotechnology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Animal Biotechnology Market Size by Region (2021-2026)
  5. 3.2.3 Global Animal Biotechnology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Animal Biotechnology Revenue by Players
  2. 4.1.1 Global Animal Biotechnology Revenue by Players (2021-2026)
  3. 4.1.2 Global Animal Biotechnology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Animal Biotechnology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Animal Biotechnology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Animal Biotechnology Key Players Headquarters & Area Served
  7. 4.4 Global Animal Biotechnology Players, Product Type & Application
  8. 4.5 Global Animal Biotechnology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Animal Biotechnology Market CR5 and HHI
  11. 4.6.3 2025 Animal Biotechnology Tier 1, Tier 2, and Tier 3
5 Animal Biotechnology Market Size by Type
  1. 5.1 Global Animal Biotechnology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Animal Biotechnology Revenue by Type (2021-2032)
  3. 5.3 Global Animal Biotechnology Revenue Market Share by Type (2021-2032)
6 Animal Biotechnology Market Size by Application
  1. 6.1 Global Animal Biotechnology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Animal Biotechnology Revenue by Application (2021-2032)
  3. 6.3 Global Animal Biotechnology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Biogenesis Bago
  2. 7.1.1 Biogenesis Bago Company Information
  3. 7.1.2 Biogenesis Bago Business Overview
  4. 7.1.3 Biogenesis Bago Animal Biotechnology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Biogenesis Bago Animal Biotechnology Product Portfolio
  6. 7.1.5 Biogenesis Bago Recent Developments
  7. 7.2 Boehringer Inghlem
  8. 7.2.1 Boehringer Inghlem Company Information
  9. 7.2.2 Boehringer Inghlem Business Overview
  10. 7.2.3 Boehringer Inghlem Animal Biotechnology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Inghlem Animal Biotechnology Product Portfolio
  12. 7.2.5 Boehringer Inghlem Recent Developments
  13. 7.3 Santa Cruz Biotechnology, Inc.
  14. 7.3.1 Santa Cruz Biotechnology, Inc. Company Information
  15. 7.3.2 Santa Cruz Biotechnology, Inc. Business Overview
  16. 7.3.3 Santa Cruz Biotechnology, Inc. Animal Biotechnology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Santa Cruz Biotechnology, Inc. Animal Biotechnology Product Portfolio
  18. 7.3.5 Santa Cruz Biotechnology, Inc. Recent Developments
  19. 7.4 Virbac Inc.
  20. 7.4.1 Virbac Inc. Company Information
  21. 7.4.2 Virbac Inc. Business Overview
  22. 7.4.3 Virbac Inc. Animal Biotechnology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Virbac Inc. Animal Biotechnology Product Portfolio
  24. 7.4.5 Virbac Inc. Recent Developments
  25. 7.5 Bayer AG
  26. 7.5.1 Bayer AG Company Information
  27. 7.5.2 Bayer AG Business Overview
  28. 7.5.3 Bayer AG Animal Biotechnology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Bayer AG Animal Biotechnology Product Portfolio
  30. 7.5.5 Bayer AG Recent Developments
  31. 7.6 Pfizer, Inc.
  32. 7.6.1 Pfizer, Inc. Company Information
  33. 7.6.2 Pfizer, Inc. Business Overview
  34. 7.6.3 Pfizer, Inc. Animal Biotechnology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer, Inc. Animal Biotechnology Product Portfolio
  36. 7.6.5 Pfizer, Inc. Recent Developments
  37. 7.7 Merck &, Inc.
  38. 7.7.1 Merck &, Inc. Company Information
  39. 7.7.2 Merck &, Inc. Business Overview
  40. 7.7.3 Merck &, Inc. Animal Biotechnology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Merck &, Inc. Animal Biotechnology Product Portfolio
  42. 7.7.5 Merck &, Inc. Recent Developments
  43. 7.8 Sanofi
  44. 7.8.1 Sanofi Company Information
  45. 7.8.2 Sanofi Business Overview
  46. 7.8.3 Sanofi Animal Biotechnology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sanofi Animal Biotechnology Product Portfolio
  48. 7.8.5 Sanofi Recent Developments
  49. 7.9 Zoetis
  50. 7.9.1 Zoetis Company Information
  51. 7.9.2 Zoetis Business Overview
  52. 7.9.3 Zoetis Animal Biotechnology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Zoetis Animal Biotechnology Product Portfolio
  54. 7.9.5 Zoetis Recent Developments
8 North America
  1. 8.1 North America Animal Biotechnology Revenue (2021-2032)
  2. 8.2 North America Animal Biotechnology Revenue by Type (2021-2032)
  3. 8.2.1 North America Animal Biotechnology Revenue by Type (2021-2026)
  4. 8.2.2 North America Animal Biotechnology Revenue by Type (2027-2032)
  5. 8.3 North America Animal Biotechnology Revenue Share by Type (2021-2032)
  6. 8.4 North America Animal Biotechnology Revenue by Application (2021-2032)
  7. 8.4.1 North America Animal Biotechnology Revenue by Application (2021-2026)
  8. 8.4.2 North America Animal Biotechnology Revenue by Application (2027-2032)
  9. 8.5 North America Animal Biotechnology Revenue Share by Application (2021-2032)
  10. 8.6 North America Animal Biotechnology Revenue by Country
  11. 8.6.1 North America Animal Biotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Animal Biotechnology Revenue by Country (2021-2026)
  13. 8.6.3 North America Animal Biotechnology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Animal Biotechnology Revenue (2021-2032)
  2. 9.2 Europe Animal Biotechnology Revenue by Type (2021-2032)
  3. 9.2.1 Europe Animal Biotechnology Revenue by Type (2021-2026)
  4. 9.2.2 Europe Animal Biotechnology Revenue by Type (2027-2032)
  5. 9.3 Europe Animal Biotechnology Revenue Share by Type (2021-2032)
  6. 9.4 Europe Animal Biotechnology Revenue by Application (2021-2032)
  7. 9.4.1 Europe Animal Biotechnology Revenue by Application (2021-2026)
  8. 9.4.2 Europe Animal Biotechnology Revenue by Application (2027-2032)
  9. 9.5 Europe Animal Biotechnology Revenue Share by Application (2021-2032)
  10. 9.6 Europe Animal Biotechnology Revenue by Country
  11. 9.6.1 Europe Animal Biotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Animal Biotechnology Revenue by Country (2021-2026)
  13. 9.6.3 Europe Animal Biotechnology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Animal Biotechnology Revenue (2021-2032)
  2. 10.2 China Animal Biotechnology Revenue by Type (2021-2032)
  3. 10.2.1 China Animal Biotechnology Revenue by Type (2021-2026)
  4. 10.2.2 China Animal Biotechnology Revenue by Type (2027-2032)
  5. 10.3 China Animal Biotechnology Revenue Share by Type (2021-2032)
  6. 10.4 China Animal Biotechnology Revenue by Application (2021-2032)
  7. 10.4.1 China Animal Biotechnology Revenue by Application (2021-2026)
  8. 10.4.2 China Animal Biotechnology Revenue by Application (2027-2032)
  9. 10.5 China Animal Biotechnology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Animal Biotechnology Revenue (2021-2032)
  2. 11.2 Asia Animal Biotechnology Revenue by Type (2021-2032)
  3. 11.2.1 Asia Animal Biotechnology Revenue by Type (2021-2026)
  4. 11.2.2 Asia Animal Biotechnology Revenue by Type (2027-2032)
  5. 11.3 Asia Animal Biotechnology Revenue Share by Type (2021-2032)
  6. 11.4 Asia Animal Biotechnology Revenue by Application (2021-2032)
  7. 11.4.1 Asia Animal Biotechnology Revenue by Application (2021-2026)
  8. 11.4.2 Asia Animal Biotechnology Revenue by Application (2027-2032)
  9. 11.5 Asia Animal Biotechnology Revenue Share by Application (2021-2032)
  10. 11.6 Asia Animal Biotechnology Revenue by Country
  11. 11.6.1 Asia Animal Biotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Animal Biotechnology Revenue by Country (2021-2026)
  13. 11.6.3 Asia Animal Biotechnology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Animal Biotechnology Revenue (2021-2032)
  2. 12.2 SAMEA Animal Biotechnology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Animal Biotechnology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Animal Biotechnology Revenue by Type (2027-2032)
  5. 12.3 SAMEA Animal Biotechnology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Animal Biotechnology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Animal Biotechnology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Animal Biotechnology Revenue by Application (2027-2032)
  9. 12.5 SAMEA Animal Biotechnology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Animal Biotechnology Revenue by Country
  11. 12.6.1 SAMEA Animal Biotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Animal Biotechnology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Animal Biotechnology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst